| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 95.580 | 134.875 | 177.380 | 502.323 | 246.503 | 513.446 | 452.961 | 468.987 | 469.047 |
| Total Income - EUR | - | 100.987 | 192.035 | 301.904 | 523.815 | 287.705 | 540.824 | 475.564 | 518.794 | 495.085 |
| Total Expenses - EUR | - | 82.247 | 133.010 | 197.755 | 251.023 | 187.754 | 357.105 | 415.448 | 394.551 | 405.869 |
| Gross Profit/Loss - EUR | - | 18.740 | 59.025 | 104.149 | 272.792 | 99.951 | 183.719 | 60.116 | 124.243 | 89.216 |
| Net Profit/Loss - EUR | - | 16.573 | 55.482 | 101.393 | 267.757 | 97.379 | 178.648 | 55.516 | 119.868 | 69.396 |
| Employees | - | 1 | 1 | 1 | 2 | 1 | 3 | 5 | 7 | 7 |
Check the financial reports for the company - Alcos Bioprod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 49.492 | 47.704 | 60.171 | 281.909 | 314.250 | 394.314 | 464.115 | 487.942 | 520.113 |
| Current Assets | - | 25.166 | 90.490 | 158.736 | 236.681 | 333.708 | 316.340 | 220.072 | 299.621 | 256.993 |
| Inventories | - | 15.396 | 46.900 | 43.556 | 59.667 | 125.704 | 120.981 | 128.335 | 137.539 | 106.279 |
| Receivables | - | 8.355 | 32.410 | 108.830 | 174.906 | 201.026 | 140.054 | 79.668 | 86.689 | 95.751 |
| Cash | - | 1.415 | 11.181 | 6.350 | 2.108 | 6.978 | 55.305 | 12.069 | 75.392 | 14.755 |
| Shareholders Funds | - | 16.618 | 71.862 | 172.022 | 436.447 | 525.553 | 581.895 | 516.949 | 574.263 | 595.395 |
| Social Capital | - | 45 | 88 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | - | 58.295 | 66.415 | 46.905 | 82.502 | 122.067 | 128.512 | 167.372 | 213.857 | 182.337 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 587 | 262 | 66 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "129 - 129" | |||||||||
| CAEN Financial Year |
129
|
|||||||||
Comments - Alcos Bioprod S.r.l.